Patients must have neurofibromatosis type 1 (NF1) based on clinical criteria and/or germline genetic testing* Patients must be newly diagnosed or have previously diagnosed NF-1 associated LGG that has not been treated with any modality other than surgery. Here, NF1 is linked to neurofibromatosis.